VERIGRAFT has announced the initiation of a pivotal Phase II/III trial of its P-TEV (personalized tissue engineered vein) in patients with chronic venous insufficiency (CVI)
“With P-TEV, we are addressing a large, underserved patient population with a therapy designed to address the underlying cause of disease, not just manage the symptoms. The initiation of our pivotal trial brings us significantly closer to making this a clinical reality,” says Petter Björquist, CEO, Verigraft.
BrainLink Health, has surged into the Top 5 finalists at Techarena 2026!
Starting the week as part of the TOP46, BrainLink has impressed the judges with their groundbreaking wireless brain pressure monitoring system. Their patented solution is a potential game-changer for the 19 million people - including 7 million children living with hydrocephalus globally.
Detectivio has published a study in Sensors on contactless measurement of heart rate and respiratory rate from facial video.
The study measured over 98 percent agreement with reference measurements based on 15-second video clips. Detectivio shows that advanced AI algorithms can combine extreme speed with the medical precision required in healthcare. The results are a solution towards faster and more accessible monitoring in digital healthcare flows.
Omaia & Cuviva AB are featured on Startup Rise Europe News as Innovative Swedish HealthTech Startups to watch in 2026
Sweden continues to be a powerhouse in digital health innovation, combining strong research, tech talent, and patient-centric solutions. From AI-powered diagnostics to digital therapeutics and women’s health, these startups are shaping the future of healthcare, with other industry giants like KRY, Natural cycles and Doctrin.